DK1232746T3 - Farmaceutisk sammensætning indeholdende xanthan gummi - Google Patents

Farmaceutisk sammensætning indeholdende xanthan gummi

Info

Publication number
DK1232746T3
DK1232746T3 DK01200507T DK01200507T DK1232746T3 DK 1232746 T3 DK1232746 T3 DK 1232746T3 DK 01200507 T DK01200507 T DK 01200507T DK 01200507 T DK01200507 T DK 01200507T DK 1232746 T3 DK1232746 T3 DK 1232746T3
Authority
DK
Denmark
Prior art keywords
xanthan gum
pharmaceutical composition
composition containing
containing xanthan
suspension
Prior art date
Application number
DK01200507T
Other languages
Danish (da)
English (en)
Inventor
Peter Meijlink
De Lockand Petrus Richardu Van
Original Assignee
Forte Iq B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8179884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1232746(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Forte Iq B V filed Critical Forte Iq B V
Application granted granted Critical
Publication of DK1232746T3 publication Critical patent/DK1232746T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
DK01200507T 2001-02-14 2001-02-14 Farmaceutisk sammensætning indeholdende xanthan gummi DK1232746T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01200507A EP1232746B1 (fr) 2001-02-14 2001-02-14 Composition pharmaceutique contenant de la gomme de xanthane

Publications (1)

Publication Number Publication Date
DK1232746T3 true DK1232746T3 (da) 2006-10-23

Family

ID=8179884

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01200507T DK1232746T3 (da) 2001-02-14 2001-02-14 Farmaceutisk sammensætning indeholdende xanthan gummi

Country Status (7)

Country Link
EP (1) EP1232746B1 (fr)
AT (1) ATE329578T1 (fr)
CY (1) CY1105540T1 (fr)
DE (1) DE60120630T2 (fr)
DK (1) DK1232746T3 (fr)
ES (1) ES2266084T3 (fr)
PT (1) PT1232746E (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291015A1 (fr) 2001-09-10 2003-03-12 Lunamed AG Compositions à libération prolongée d'un agent actif
ES2245891B1 (es) * 2004-07-09 2006-11-16 Clinmet S.L. "metodo para la obtencion de un excipiente universal para la administracion oral de principios activos farmaceuticos y composiciones de excipientes resultantes del metodo".
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
FR2881321B1 (fr) 2005-02-03 2008-12-26 Axiss France Sas Soc Par Actio Additif alimentaire pour ruminants a base d'eugenol et de cinnamaldehyde
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
CN108096193A (zh) * 2017-12-26 2018-06-01 兆科药业（广州）有限公司 一种苯丁酸钠散剂及其制备方法
CN114432241B (zh) * 2021-12-21 2023-07-14 上海奥全生物医药科技有限公司 一种快速分散的助悬组合物、制备方法及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8807582A (pt) * 1987-06-25 1990-05-29 Dentab Inc Tablete e processo de fluoretacao e limpeza de dente e tablete de limpeza de dente isento de agua
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
RO115412B1 (ro) * 1993-10-01 2000-02-28 Syntex Inc Compozitie farmaceutica si procedeu de obtinere a compozitiei farmaceutice
GB9521707D0 (en) * 1995-10-24 1996-01-03 Zeneca Ltd Improved granule composition
US5712310A (en) * 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US6074987A (en) * 1998-05-28 2000-06-13 Bayer Corporation Inhibiting phase separation in low viscosity water-based pesticide suspensions

Also Published As

Publication number Publication date
ES2266084T3 (es) 2007-03-01
PT1232746E (pt) 2006-11-30
EP1232746A1 (fr) 2002-08-21
DE60120630T2 (de) 2007-05-24
ATE329578T1 (de) 2006-07-15
DE60120630D1 (de) 2006-07-27
CY1105540T1 (el) 2010-07-28
EP1232746B1 (fr) 2006-06-14

Similar Documents

Publication Publication Date Title
NO20034230L (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
IL150986A0 (en) 1,2,3,4,- tetrahydroisoquinoline derivatives
ES2174517T3 (es) Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
MY125651A (en) Eplerenone compositions
PT1257260E (pt) Formulacao de po
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
WO2004033418A3 (fr) Derives d'acide sulfonylamino-acetique
EA200601588A1 (ru) Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств
MY129150A (en) Novel sulfamides
SI1499607T1 (sl) 4-(piperidil- in pirolidil-alkil-ureido)-kinolinikot antagonisti receptorja urotensina II
MXPA03006890A (es) Composiciones cosmeticas anhidras autogeneradoras de calor, especialmente composiciones anhidras acondicionadoras del cabello.
WO2004026836A3 (fr) Derives de 1-pyridin-4-yl-uree
CA2493176A1 (fr) Compositions visqueuses contenant des liquides hydrophobes
CA2361402A1 (fr) Bis-sulfonamides
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
HUP0202786A2 (hu) Ektoparaziticid hatású, spinosinalapú készítmény, előállítása és alkalmazása
DK1019033T3 (da) Ny formulering til inhalation der har en hældt bulkdensitet på fra 0,28 til 0,38 g/ml, som omfatter budesonid
CY1105540T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει ξανθανικο κομμι
ATE315395T1 (de) Pharmazeutische zusammensetzungen, die faropenem natrium und eine diamineacetat verbindung zur verbesserung der magen-darm trakt absorption enthalten
MXPA03000430A (es) Nuevas arileteno-sulfonamidas.
HUP0202744A2 (hu) Orális, rivasztigmint tartalmazó szabályozott hatóanyag-leadású készítmények
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon